What is it and how is it used?

Corlentor (ivabradine) is a heart medicine used to treat stable angina pectoris which causes chest pain. It is used in adult patients who do not tolerate or cannot take heart medicines called beta-blockers. It is also used in combination with beta-blockers in adult patients whose condition is not fully controlled with a beta-blocker and whose heart rate is too high (over 60 beats per minute).

About stable angina pectoris (usually referred to as ?angina?):
Stable angina is a heart disease which happens when the heart does not receive enough oxygen. It usually appears between 40 and 50 years of age. The most common symptom of angina is chest pain or discomfort. Angina is more likely to happen when the heart beats faster in situations such as exercise, emotion, exposure to the cold or after eating. This increase in heart rate can cause the chest pain in people who suffer from angina.

How does Corlentor work?
Corlentor mainly works by reducing the heart rate by a few beats per minute. This lowers the heart?s need for oxygen especially in the situations when an angina attack is more likely to happen. In this way Corlentor helps to control and reduce the number of angina attacks.

What do you have to consider before using it?

Do not take Corlentor

  • if you are allergic (hypersensitive) to ivabradine or any of the other ingredients of Corlentor (see ?further information? for a list of all ingredients);
  • if your resting heart rate before treatment is too slow (below 60 beats per minute);
  • if you are suffering from cardiogenic shock (a heart condition treated in hospital);
  • if you suffer from a heart rhythm disorder;
  • if you are having a heart attack;
  • if you suffer from very low blood pressure;
  • if you suffer from unstable angina (a severe form in which chest pain occurs very frequently and with or without exertion);
  • if you suffer from severe heart failure (when your heart fails to work properly);
  • if you have a pacemaker;
  • if you suffer from severe liver problems;
  • if you are already taking medicines for the treatment of fungal infections (such as ketoconazole, itraconazole), macrolide antibiotics (such as josamycin, clarithromycin, telithromycin or erythromycin given orally), medicines to treat HIV infections (such as nelfinavir, ritonavir) or nefazodone (medicine to treat depression) (see ?Taking other medicines?);
  • if you are pregnant;
  • if you are breast-feeding.
Take special care with Corlentor

  • if you suffer from heart rhythm disorders (such as irregular heartbeat, palpitation, increase in chest pain) or sustained atrial fibrillation (a type of irregular heartbeat),
  • if you have symptoms such as tiredness, dizziness or shortness of breath (this could mean that your heart is slowing down too much),
  • if you have had a recent stroke (cerebral attack),
  • if you suffer from mild to moderate low blood pressure,
  • if you suffer from chronic heart failure (when your heart fails to work properly),
  • if you suffer from chronic eye retinal disease,
  • if you suffer from moderate liver problems,
  • if you suffer from severe renal problems. If any of the above applies to you, talk straight away to your doctor before or while taking Corlentor.

Children
Corlentor is not intended for use in children and adolescents younger than 18 years.

Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Make sure to tell your doctor if you are taking any of the following medicines, as a dose adjustment of Corlentor or monitoring should be required:

  • diltiazem, verapamil (used for high blood pressure or angina pectoris)
  • fluconazole (an antifungal medicine)
  • rifampicin (an antibiotic)
  • barbiturates (for difficult sleeping or epilepsy)
  • phenytoin (for epilepsy)
  • Hypericum perforatum or St John?s Wort (herbal treatment for depression)
  • QT prolonging medicines to treat either heart rhythm disorders or other conditions :
  • quinidine, disopyramide, ibutilide, sotalol, amiodarone (to treat heart rhythm disorders)
  • bepridil (to treat angina pectoris)
  • certain types of medicines to treat anxiety, schizophrenia or other psychoses (such as pimozide, ziprasidone, sertindole)
  • anti-malarial medicines (such as mefloquine or halofantrine)
  • intravenous erythromycin (an antibiotic)
  • pentamidine (an antiparasitic medicine)
  • cisapride (against the gastro-oesophageal reflux)

Taking Corlentor with food and drink

Limit your consumption of grapefruit juice during treatment with Corlentor.

Pregnancy and breast-feeding

Do not take Corlentor if you are pregnant or planning a pregnancy (see ?Do not take Corlentor?).If you are pregnant and have taken Corlentor, talk to your doctor.
Do not take Corlentor if you are breast-feeding (see ?Do not take Corlentor?).
Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines
Corlentor may cause temporary luminous visual phenomena (a temporary brightness in the field of vision, see ?Possible side effects?). If this happens to you, be careful when driving or using machines at times when there could be sudden changes in light intensity, especially when driving at night.

Important information about some of the ingredients of Corlentor

Corlentor contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

How is it used?

Always take Corlentor exactly as your doctor has told you.You should check with your doctor or pharmacist if you are not sure. The usual recommended starting dose is one tablet of Corlentor 5 mg twice daily increasing if necessary to one tablet of Corlentor 7.5 mg twice daily. Your doctor will decide the right dose for you. The usual dose is one tablet in the morning and one tablet in the evening. In some cases (e.g. if you are elderly), your doctor may prescribe half the dose i.e., one half 5 mg tablet of Corlentor 5 mg (corresponding to 2.5 mg ivabradine) in the morning and one half 5 mg tablet in the evening.
Corlentor should be taken during meals.

If you take more Corlentor than you should
A large dose of Corlentor could make you feel breathless or tired because your heart slows down too much. If this happens, contact your doctor immediately.

If you forget to take Corlentor
If you forget to take a dose of Corlentor, take the next dose at the usual time. Do not take a double dose to make up for the forgotten dose.
The calendar printed on the blister containing the tablets should help you remember when you last took a tablet of Corlentor.

If you stop taking Corlentor

As the treatment for angina is usually life-long, you should discuss with your doctor before stopping this medicinal product.

If you think that the effect of Corlentor is too strong or too weak, talk to your doctor or pharmacist.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

What are possible side effects?

Like all medicines, Corlentor can cause side effects, although not everybody gets them.

The frequency of possible side effects listed below is defined using the following convention: very common (affects more than 1 user in 10)
common (affects 1 to 10 users in 100)
uncommon (affects 1 to 10 users in 1,000)
rare (affects 1 to 10 users in 10,000)
very rare (affects less than 1 user in 10,000)
not known (frequency cannot be estimated from the available data)

Very common:
Luminous visual phenomena (brief moments of increased brightness, most often caused by sudden changes in light intensity).

Common:

Modification in the heart functioning (the symptoms are a slowing down of the heart rate), abnormal perception of heartbeat, headache, dizziness and blurred vision.

Uncommon:

Palpitations and cardiac extra beats, feeling sick (nausea), constipation, diarrhoea, spinning sensation (vertigo), difficulty breathing (dyspnoea), muscle cramps and changes in laboratory parameters: high blood levels of uric acid, an excess of eosinophils (a type of white blood cell) and elevated creatinine in blood (a breakdown product of muscle).

Not known:

Itching, skin rash, skin reddening, low blood pressure, feeling of faintness, syncope.

If any of the side effects gets serious of if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

How should it be stored?

Keep out of the reach and sight of children.

Do not use Corlentor after the expiry date which is stated on the carton and blister after ?EXP?. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Further information

What Corlentor contains

  • The active substance is ivabradine (as hydrochloride). Corlentor 5 mg: one film-coated tablet contains 5 mg ivabradine (equivalent to 5.390 mg ivabradine as hydrochloride). Corlentor 7.5 mg: one film-coated tablet contains 7.5 mg ivabradine (equivalent to 8.085 mg ivabradine as hydrochloride).
  • The other ingredients in the tablet core are: lactose monohydrate, magnesium stearate (E 470 B), maize starch, maltodextrin, colloidal anhydrous silica (E 551), and in the tablet coating: hypromellose (E 464), titanium dioxide (E 171), macrogol 6000, glycerol (E 422), magnesium stearate (E 470 B), yellow iron oxide (E 172), red iron oxide (E 172).

What Corlentor looks like and contents of the pack

Corlentor 5 mg tablets are salmon-coloured, oblong film-coated tablets scored on both sides, engraved with ?5? on one face and on the other.
Corlentor 7.5 mg tablets are salmon-coloured, triangular, film-coated tablets engraved with ?7.5? on one face and on the other.

The tablets are available in calendar packs (Aluminium/PVC blisters) of 14, 28, 56, 84, 98, 100 or 112 tablets.
Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Les Laboratoires Servier

22 rue Garnier
92200 Neuilly sur Seine - France

Manufacturer:
Les Laboratoires Servier Industrie
905 route de Saran
45520 Gidy ? France

Servier (Ireland) Industries Ltd

Gorey Road

Arklow - Co. Wicklow ? Ireland

Przedsiebiorstwo Farmaceutyczne ANPHARM S.A.

ul. Annopol 6B ? 03-236 Warszawa ? Poland

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.

BelgiëBelgiqueBelgien S.A. Servier Benelux N.V. TélTel 32 02 529 43 11 LuxembourgLuxemburg S.A. Servier Benelux N.V. TélTel 32 02 529 43 11

. 359 2 921 57 00 Magyarország Servier Hungaria Kft. Tel. 36 1 238 77 99

eská republika Servier s.r.o. Tel 420 222 118 111 Malta GALEPHARMA Ltd Tel 356 21 247 082

Danmark Servier Danmark AS Tlf 45 36 44 22 60 Nederland Servier Nederland Farma B.V. Tel 31 071 5246700

Deutschland Servier Deutschland GmbH Tel 49 089 57095 01 Norge Servier Danmark AS Tlf 45 36 44 22 60

Eesti CentralPharma Communications OÜ Tel 372 640 00 07 Österreich Servier Austria GmbH Tel 43 1 524 39 99

30 210 939 1000 Polska Servier Polska SP. Z O.O. Tel. 48 0 22 594 90 00

España Laboratorios Farmacéuticos Rovi, S.A. Tel 34 91 375 62 30 Portugal Servier Portugal, Lda Tel 351 21 312 20 00

France Les Laboratoires Servier Tél 33 01 55 72 60 00 România Servier Pharma SRL Tel 4 021 528 52 80

Ireland Slovenija

Servier Laboratories Ireland Ltd. Tel 353 01 6638110 Servier Pharma d.o.o. Tel 386 01 563 48 11

Slovenská republika Servier Slovensko spol. s r.o. Tel 421 02 5920 41 11 Ísland Servier Laboratories Co Icepharma hf Sími 354 540 8000

Italia Istituto Farmaco Biologico Stroder S.r.l. Tel 39 055 623271 SuomiFinland Servier Finland Oy PuhTel 358 09 279 80 80

.. 357 22741741 Sverige Servier Sverige AB Tel 46 85 225 08 00

United Kingdom Servier Laboratories Ltd Tel 44 01 753 666409 Latvija SIA Servier Latvia Tel 371 67502039

Lietuva
UAB ?SERVIER PHARMA?
Tel: +370 (5) 2 63 86 28

This leaflet was last approved in

Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK